Volume 23 Issue 11
Nov.  2025
Turn off MathJax
Article Contents
Dilihumaer·Aili, Zainula·Yiming, Zulipiyemu·Xier, PENG Hui. Analysis of risk factors affecting all-cause mortality in patients with coronary artery disease with mitral regurgitation[J]. Chinese Journal of General Practice, 2025, 23(11): 1830-1833. doi: 10.16766/j.cnki.issn.1674-4152.004238
Citation: Dilihumaer·Aili, Zainula·Yiming, Zulipiyemu·Xier, PENG Hui. Analysis of risk factors affecting all-cause mortality in patients with coronary artery disease with mitral regurgitation[J]. Chinese Journal of General Practice, 2025, 23(11): 1830-1833. doi: 10.16766/j.cnki.issn.1674-4152.004238

Analysis of risk factors affecting all-cause mortality in patients with coronary artery disease with mitral regurgitation

doi: 10.16766/j.cnki.issn.1674-4152.004238
Funds:

 2022B03009-3

  • Received Date: 2024-09-27
    Available Online: 2026-01-07
  •   Objective  The incidence of coronary artery disease (CAD) continues to increase, and mitral regurgitation (MR) is the most common heart valve disease. This study aims to investigate the clinical characteristics exhibited by patients diagnosed with coronary artery disease with MR and analyze the risk factors that have a detrimental effect on their prognosis.  Methods  This study comprised 813 patients diagnosed with coronary artery disease with mitral regurgitation, who were admitted to the Xinjiang Uygur Autonomous Region People's Hospital from January 2018 to December 2023, with a median follow-up period of 2.5 years, and the primary focus of the analysis was all-cause mortality. Patients were categorized into an endpoint event group (n=314) and a non-endpoint event group (n=499) according to the occurrence of an endpoint event. A Cox regression model was used to analyze the correlation between echocardiographic indices and prognosis in the present study, and the predictive ability of left atrial diameter (LAD), left ventricular end-diastolic internal diameter (LVEDD), and left ventricular end-systolic internal diameter (LVESD) for prognosis was assessed by the subjects' operating curves (ROCs), and the optimal cut-off values were determined by the Youden index, and analyzed by using the Kaplan-Meier survival curve.  Results  After making several adjustments to the data, it was found that LAD (HR=1.031, 95% CI: 1.015-1.048), LVEDD (HR=1.057, 95% CI: 1.043-1.071), LVESD (HR=1.046, 95% CI: 1.031-1.062) were all risk factors for the occurrence of endpoint events in patients with coronary heart disease and MR (P < 0.001). The ROC curve showed that LAD, LVEDD and LVESD could predict long-term all-cause death in patients with coronary heart disease and MR (AUC=0.666, 0.755, 0.761, P < 0.001), and the best cut-off values were 42.5 mm, 49.5 mm and 37.5 mm, respectively. The Kaplan-Meier survival curve showed that the survival rate of patients above the threshold was significantly reduced (log-rank χ2=59.737, 123.156, 171.803, P < 0.001).  Conclusion  Cardiac echocardiographic indices have been shown to possess a degree of predictive value regarding prognosis in patients suffering from coronary artery disease and mitral regurgitation, and the increase of LAD, LVEDD and LVESD has been identified as a risk factor for endpoint events in patients.

     

  • loading
  • [1]
    YAN Z S, ZHANG N C, LI K, et al. Upregulation of long non-coding RNA myocardial infarction-associated transcription is correlated with coronary artery stenosis and elevated inflammation in patients with coronary atherosclerotic heart disease[J]. Kaohsiung J Med Sci, 2021, 37(12): 1038-1047. doi: 10.1002/kjm2.12444
    [2]
    黄万众, 苏强. 冠心病与精神心理疾病的相关性与研究现状[J]. 中华全科医学, 2024, 22(7): 1212-1216.

    HUANG W Z, SU Q. The correlation and research status of coronary heart disease and psychiatric disorders[J]. Chinese Journal of General Practice, 2024, 22(7): 1212-1216.
    [3]
    VAHANIAN A, BEYERSDORF F, PRAZ F, et al. 2021 ESC/EACTS Guidelines for the management of valvular heart disease: developed by the Task Force for the management of valvular heart disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)[J]. Eur Heart J, 2022, 43(7): 561-632. doi: 10.1093/eurheartj/ehab395
    [4]
    董桂福, 王宇航, 葛建军. 不停跳冠脉搭桥心肌保护技术在瓣膜疾病合并冠心病手术中的应用[J]. 中华全科医学, 2021, 19(10): 1650-1653.

    DONG G F, WANG Y H, GE J J. Application analysis of myocardial protection technique for off-pump coronary artery bypass grafting in the operation of valve disease combined with coronary heart disease[J]. Chinese Journal of General Practice, 2021, 19(10): 1650-1653.
    [5]
    ZEGARD A, OKAFOR O, DE BONO J, et al. Myocardial fibrosis as a predictor of sudden death in patients with coronary artery disease[J]. J Am Coll Cardiol, 2021, 77(1): 29-41. doi: 10.1016/j.jacc.2020.10.046
    [6]
    ARORA S, SIVARAJ K, HENDRICKSON M, et al. Prevalence and prognostic significance of mitral regurgitation in acute decompensated heart failure: the ARIC study[J]. JACC Heart Fail, 2021, 9(3): 179-189. doi: 10.1016/j.jchf.2020.09.015
    [7]
    HARADA T, NASER J A, TADA A, et al. Cardiac function, haemodynamics, and valve competence with exercise in patients with heart failure with preserved ejection fraction and mild to moderate secondary mitral regurgitation[J]. Eur J Heart Fail, 2024, 26(7): 1616-1627. doi: 10.1002/ejhf.3322
    [8]
    COLLET J P, THIELE H, BARBATO E, et al. 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: the Task Force for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC)[J]. Eur Heart J, 2021, 42(14): 1289-1367. doi: 10.1093/eurheartj/ehaa575
    [9]
    MARCHETTI D, DI LENARDA F, NOVEMBRE M L, et al. Contemporary echocardiographic evaluation of mitral regurgitation and guidance for percutaneous mitral valve repair[J]. J Clin Med, 2023, 12(22): 7121. DOI: 10.3390/jcm12227121.
    [10]
    RETHEMIOTAKI I. Global prevalence of cardiovascular diseases by gender and age during 2010-2019[J]. Arch Med Sci Atheroscler Dis, 2023, 8: e196-e205.
    [11]
    O'GARA P T, MACK M J. Secondary mitral regurgitation[J]. N Engl J Med, 2020, 383(15): 1458-1467. doi: 10.1056/NEJMcp1903331
    [12]
    CHEHAB O, ROBERTS-THOMSON R, NG YIN LING C, et al. Secondary mitral regurgitation: pathophysiology, proportionality and prognosis[J]. Heart, 2020, 106(10): 716-723. doi: 10.1136/heartjnl-2019-316238
    [13]
    VON JEINSEN B, SHORT M I, LARSON M G, et al. Prognostic significance of echocardiographic measures of cardiac remodeling[J]. J Am Soc Echocardiogr, 2020, 33(1): 72-81. doi: 10.1016/j.echo.2019.08.001
    [14]
    FERNANDES L P, BARRETO A T F, NETO M G, et al. Prognostic power of conventional echocardiography in individuals without history of cardiovascular diseases: a systematic review and meta-analysis[J]. Clinics (Sao Paulo), 2021, 76: e2754. DOI: 10.6061/clinics/2021/e2754.
    [15]
    ZILBERSZAC R, GLEISS A, MASSETTI M, et al. Left atrial size predicts outcome in severe but asymptomatic mitral regurgitation[J]. Sci Rep, 2023, 13(1): 3892. DOI: 10.1038/s41598-023-31163-0.
    [16]
    李雨濛, 吴华芹, 张并璇, 等. 左室舒张末期内径对慢性心力衰竭患者远期预后的预测价值[J]. 中国循证心血管医学杂志, 2022, 14(11): 1341-1344, 1348.

    LI Y M, WU H Q, ZHANG B X, et al. Predictive value of left ventricular end-diastolic inner diameter to long-term prognosis in patients with chronic heart failure[J]. Chinese Journal of Evidence-Based Cardiovascular Medicine, 2022, 14(11): 1341-1344, 1348.
    [17]
    DUGGAN J P, PETERS A S, TRACHIOTIS G D, et al. Epidemiology of coronary artery disease[J]. Surg Clin North Am, 2022, 102(3): 499-516. doi: 10.1016/j.suc.2022.01.007
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Figures(4)  / Tables(3)

    Article Metrics

    Article views (47) PDF downloads(1) Cited by()
    Proportional views
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return